drugset / Trial / NCT03750383
Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects
Phase 1
Completed
48 enrolled
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates · collab
Non-randomizedSingle-groupOpen-labelBasic science
Summary
A Non-Randomized, Open-Label, Two-Part, Drug-Drug Interaction Study to Evaluate the Effects of Cyclosporine and Prednisone on the Pharmacokinetics and Safety of EDP-938 in Healthy Adult Subjects
Timeline
- Start
- 2018-11-02
- Primary completion
- 2018-11-17
- Completion
- 2018-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | — | — |
| Subject | Prednisone | Other / unclassified | — | — |
| Subject | zelicapavir | Small molecule | — | — |